We are live on
!
Find out more
Bank Julius Baer & Co Portfolio holdings
AUM
$38.6B
1-Year Est. Return
35.31%
This Fund
S&P 500
This Quarter
Est. Return
+11.03%
1 Year Est. Return
+35.31%
3 Year Est. Return
+114.04%
5 Year Est. Return
+141.38%
10 Year Est. Return
–
AUM
$12.2B
AUM Growth
+$1.94B
(+19%)
Cap. Flow
+$966M
Cap. Flow
% of AUM
7.93%
Top 10 Holdings %
Top 10 Hldgs %
35.71%
Holding
880
New
146
Increased
371
Reduced
267
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$249M |
| 2 |
PayPal
PYPL
|
+$72.8M |
| 3 |
MarketAxess Holdings
MKTX
|
+$69.9M |
| 4 |
Idexx Laboratories
IDXX
|
+$69.2M |
| 5 |
NVIDIA
NVDA
|
+$67.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$257M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$110M |
| 3 |
VMW
VMware, Inc
VMW
|
+$83.9M |
| 4 |
TJX Companies
TJX
|
+$72.9M |
| 5 |
CME Group
CME
|
+$62.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 13.02% |
| 4 | Communication Services | 9.27% |
| 5 | Consumer Discretionary | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRMN
476
Garmin
GRMN
$60.1B
| $435K | ﹤0.01% |
3,635
-555
| -13% | -$61.5K |
|
477
Meritage Homes
MTH
$4.75B
| $429K | ﹤0.01% |
10,360
+3,580
| +53% | +$169K |
|
478
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.58B
| $427K | ﹤0.01% |
12,889
+50
| +0.4% | +$1.53K |
|
479
Hormel Foods
HRL
$13.3B
| $422K | ﹤0.01% |
9,054
+456
| +5% | +$22.2K |
|
480
Tandem Diabetes Care
TNDM
$1.59B
| $421K | ﹤0.01% |
4,400
| – | – |
|
481
Zillow
Z
$7.67B
| $421K | ﹤0.01% |
3,243
-4,787
| -60% | -$529K |
|
|
CHN
482
DELISTED
China Fund
CHN
| $416K | ﹤0.01% |
14,566
-5
| -0% | -$143 |
|
483
Regeneron Pharmaceuticals
REGN
$82.9B
| $416K | ﹤0.01% |
861
+148
| +21% | +$79.9K |
|
484
ARK Innovation ETF
ARKK
$6.4B
| $409K | ﹤0.01% |
+3,285
| New | +$356K |
|
485
Digital Realty Trust
DLR
$71.2B
| $407K | ﹤0.01% |
2,917
+1,535
| +111% | +$220K |
|
486
Henry Schein
HSIC
$10B
| $401K | ﹤0.01% |
5,998
-2
| -0% | -$129 |
|
487
Wayfair
W
$14.5B
| $399K | ﹤0.01% |
1,767
-478
| -21% | -$127K |
|
488
Intercontinental Exchange
ICE
$84.6B
| $398K | ﹤0.01% |
3,452
-96
| -3% | -$9.96K |
|
489
Freshpet
FRPT
$3.33B
| $397K | ﹤0.01% |
+2,796
| New | +$361K |
|
490
Arcus Biosciences
RCUS
$3.61B
| $383K | ﹤0.01% |
14,753
-11,196
| -43% | -$271K |
|
|
WW
491
DELISTED
WW International
WW
| $380K | ﹤0.01% |
15,574
-816
| -5% | -$21.2K |
|
492
iShares China Large-Cap ETF
FXI
$4.26B
| $376K | ﹤0.01% |
8,098
-2
| -0% | -$91 |
|
|
CTXS
493
DELISTED
Citrix Systems Inc
CTXS
| $371K | ﹤0.01% |
2,852
-1,121
| -28% | -$143K |
|
494
CSX Corp
CSX
$93B
| $369K | ﹤0.01% |
12,198
-14,079
| -54% | -$404K |
|
495
Hewlett Packard
HPE
$71.3B
| $367K | ﹤0.01% |
30,970
-139
| -0.4% | -$1.46K |
|
496
F5
FFIV
$23.7B
| $363K | ﹤0.01% |
2,063
+1,257
| +156% | +$191K |
|
497
Intellia Therapeutics
NTLA
$1.66B
| $357K | ﹤0.01% |
+6,563
| New | +$238K |
|
498
Best Buy
BBY
$17.7B
| $349K | ﹤0.01% |
3,497
-1,501
| -30% | -$168K |
|
499
Logitech
LOGI
$15B
| $345K | ﹤0.01% |
3,550
| – | – |
|
500
Kroger
KR
$34.4B
| $339K | ﹤0.01% |
10,674
-14,140
| -57% | -$458K |
|
Similar funds
Bank Julius Baer & Co's Q4 2020 Portfolio in Review
As of Q4 2020, Bank Julius Baer & Co held 880 positions worth $12.2B, up 19% from $10.2B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Bank Julius Baer & Co deployed $966M of net new capital in Q4 2020, opening 146 new positions and adding to 371 existing holdings. Its largest new stake was Deckers Outdoor: 641,742 shares worth $30.7M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $257M trimmed.
- Bank Julius Baer & Co's largest Q4 2020 buy was Deckers Outdoor: 641,742 shares worth $30.7M.
- Bank Julius Baer & Co added most to Thermo Fisher Scientific in Q4 2020, an estimated $249M increase.
- Bank Julius Baer & Co's biggest Q4 2020 reduction was Johnson & Johnson, cutting an estimated $257M.
- Bank Julius Baer & Co fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2020, selling an estimated $110M.
- Bank Julius Baer & Co's ten largest holdings make up 36% of its $12.2B portfolio in Q4 2020.
- Bank Julius Baer & Co opened 146 new positions and closed 78 in Q4 2020.
- Bank Julius Baer & Co's portfolio value rose 19% quarter-over-quarter to $12.2B.
Based on Bank Julius Baer & Co's 13F filing for Q4 2020, filed 12 Feb 2021.